PRESS RELEASE published on 07/01/2025 at 07:30, 1 year 4 months ago CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité avec Rothschild Martin Maurel pour favoriser la liquidité des transactions. Détails du contrat et impacts sur le marché réglementé d'Euronext Contrat De Liquidité Rothschild Martin Maurel Euronext Crossject ZENEO®
BRIEF published on 06/24/2025 at 19:05, 1 year 4 months ago CROSSJECT obtient une augmentation de capital de 5,7 millions d'euros Augmentation De Capital Soumission À La FDA ZEPIZURE® Gemmes Venture Vatel Capital
BRIEF published on 06/24/2025 at 19:05, 1 year 4 months ago CROSSJECT Secures €5.7 Million in Capital Increase Capital Increase FDA Submission ZEPIZURE® Gemmes Venture Vatel Capital
PRESS RELEASE published on 06/24/2025 at 19:00, 1 year 4 months ago CROSSJECT annonce le vif succès de son augmentation de capital portée à 5,7 millions d’euros après exercice intégral de la clause d’extension CROSSJECT annonce le vif succès de son augmentation de capital à 5,7 millions d’euros après exercice intégral de la clause d’extension pour ZEPIZURE® Financement Augmentation De Capital Pharmaceutique Crossject ZEPIZURE
PRESS RELEASE published on 06/24/2025 at 19:00, 1 year 4 months ago CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause CROSSJECT successfully completes a capital increase of €5.7 million through preferential subscription rights, benefiting from new investor support and Gemmes Venture, to advance ZEPIZURE® development Capital Increase Crossject ZEPIZURE® Gemmes Venture Vatel Capital
BRIEF published on 06/11/2025 at 07:35, 1 year 5 months ago CROSSJECT progresse dans le développement de ZEPIZURE® Junior pour enfants Pédiatrie Crossject Auto-injecteur Épilepsie ZEPIZURE Junior
BRIEF published on 06/11/2025 at 07:35, 1 year 5 months ago CROSSJECT advances in the development of ZEPIZURE® Junior for children Epilepsy Pediatrics Crossject Auto-injector ZEPIZURE Junior
PRESS RELEASE published on 06/11/2025 at 07:30, 1 year 5 months ago CROSSJECT avance sur le développement de ZEPIZURE® Junior, sa solution pour les crises d'épilepsie chez l'enfant CROSSJECT progresse dans le développement de ZEPIZURE® Junior pour les crises d'épilepsie chez l'enfant, avec calibration réussie de ZENEO®. Étude clinique menée pour adapter l'injection aux enfants Crossject Enfant ZENEO® Épilepsie ZEPIZURE® Junior
PRESS RELEASE published on 06/11/2025 at 07:30, 1 year 5 months ago CROSSJECT advances on the development of ZEPIZURE® Junior, its solution for epilepsy crises in children CROSSJECT advances development of ZEPIZURE® Junior for epilepsy crises in children, completing clinical studies for effective calibration and injection depth validation Epilepsy Clinical Studies Crossject ZEPIZURE® Junior Pediatric Population
BRIEF published on 06/06/2025 at 17:50, 1 year 5 months ago Publication of Crossject voting rights and shares Share Capital Voting Rights Actions AMF Crossject
Published on 11/20/2026 at 15:00, 1 day 8 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 1 day 8 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 day 9 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 day 9 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 day 9 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 23 hours 21 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 1 day ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 1 day 1 hour ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 1 day 2 hours ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 1 day 4 hours ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 1 day 4 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day 5 hours ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 1 day 5 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 4 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR